| Oscar Morhey, | |
|
6120 Kansas Ave Ne, Washington, DC 20011-1531 | |
| (914) 356-4293 | |
| Not Available |
| Full Name | Oscar Morhey |
|---|---|
| Gender | Male |
| Speciality | Licensed Practical Nurse |
| Location | 6120 Kansas Ave Ne, Washington, District Of Columbia |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1215562467 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 164W00000X | Licensed Practical Nurse | LPN1007971 (District Of Columbia) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Oscar Morhey, 6120 Kansas Ave Ne, Washington, DC 20011-1531 Ph: () - | Oscar Morhey, 6120 Kansas Ave Ne, Washington, DC 20011-1531 Ph: (914) 356-4293 |
News Archive
Extremely low birth-weight babies are at risk for a chronic lung disease called bronchopulmonary dysplasia, or BPD.
Oxford Gene Technology, The Molecular Genetics Company, has today announced a significant expansion of its existing catalogue of Cytocell Aquarius Haematology probes for fluorescence in situ hybridisation (FISH) — underlining the company's position as the one-stop-shop for high-quality FISH probes.
In this Kaiser Health News short take, staff writer Jessica Marcy reports: "As states across the country scramble to meet the requirements for national health reform, the nation's capital is 'way ahead,' according to Dr. Julie Hudman, director of the Department of Health Care Finance and a member of the city's Health Reform Implementation Committee.
The hearings represent the first of what will likely be a long list of hearings and new legislation designed to question and denounce the new health law. With the measure in the spotlight, the debate surrounding its fiscal impact also is a "hot topic." Meanwhile, some Democrats who last year opposed the health overhaul are starting to find value in it.
After receiving a priority review, Bristol-Myers Squibb Company and Otsuka Pharmaceutical Co., Ltd. today announced that the U.S. Food and Drug Administration (FDA) has approved SPRYCEL (dasatinib) 100 mg once daily for the treatment of adult patients with newly diagnosed Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia (CML) in chronic phase.
› Verified 7 days ago
Emmanuel Mbu, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 2811 Pennsylvania Ave Se, Washington, DC 20020 Phone: 301-379-8449 | |
Stella Segun, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 6856 Eastern Ave Nw, Suite 220, Washington, DC 20012 Phone: 202-545-6980 | |
Yolanda Blagrove, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 801 Pennsylvania Ave Se, Washington, DC 20003 Phone: 202-796-0605 | |
Nwaneka Onuaku, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 6856 Eastern Ave Nw Ste 320a, Washington, DC 20012 Phone: 202-541-9844 | |
Priscillia N Moghalu, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 6856 Eastern Ave Nw, Washington, DC 20012 Phone: 202-541-9844 | |
Jasmine Rhodes, HHA, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 505 Madison St Nw, Washington, DC 20011 Phone: 202-600-6972 | |
Rochelle Fadare, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 7600 Georgia Ave Nw Ste 323, Washington, DC 20012 Phone: 202-723-3060 Fax: 202-723-3065 |